Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Solomon

Showing results (201-210 of 208) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 208 results.
Acta Neuropathologica|September 14, 2019
Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomasEmily A Sloan, Tabitha Cooney, Nancy Ann Oberheim Bush, et al.
Acta Neuropathologica Communications|August 30, 2020
Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumorCalixto-Hope G Lucas, Rohit Gupta, Pamela Doo, et al.
Neuro-Oncology|January 22, 2026
Intracranial mesenchymal tumor, FET::CREB fusion-positive: an integrative analysis of 81 casesSharika Rajan, Hye-Jung Chung, Zhichao Wu, et al.
Acta Neuropathologica|February 14, 2023
Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplificationMichaela-Kristina Keck, Martin Sill, Andrea Wittmann, et al.
Acta Neuropathologica|November 27, 2022
Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplificationMichaela-Kristina Keck, Martin Sill, Andrea Wittmann, et al.
Nature Medicine|November 9, 2023
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responsesWilliam C Chen, Abrar Choudhury, Mark W Youngblood, et al.
The Lancet. Oncology|May 14, 2018
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohortSebastian M Waszak, Paul A Northcott, Ivo Buchhalter, et al.
Cancer Discovery|April 3, 2020
Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable OutcomesMatthew Clarke, Alan Mackay, Britta Ismer, et al.
Pageof 21

Showing results (201-210 of 208) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 208 results.
Acta Neuropathologica|September 14, 2019
Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomasEmily A Sloan, Tabitha Cooney, Nancy Ann Oberheim Bush, et al.
Acta Neuropathologica Communications|August 30, 2020
Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumorCalixto-Hope G Lucas, Rohit Gupta, Pamela Doo, et al.
Neuro-Oncology|January 22, 2026
Intracranial mesenchymal tumor, FET::CREB fusion-positive: an integrative analysis of 81 casesSharika Rajan, Hye-Jung Chung, Zhichao Wu, et al.
Acta Neuropathologica|February 14, 2023
Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplificationMichaela-Kristina Keck, Martin Sill, Andrea Wittmann, et al.
Acta Neuropathologica|November 27, 2022
Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplificationMichaela-Kristina Keck, Martin Sill, Andrea Wittmann, et al.
Nature Medicine|November 9, 2023
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responsesWilliam C Chen, Abrar Choudhury, Mark W Youngblood, et al.
The Lancet. Oncology|May 14, 2018
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohortSebastian M Waszak, Paul A Northcott, Ivo Buchhalter, et al.
Cancer Discovery|April 3, 2020
Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable OutcomesMatthew Clarke, Alan Mackay, Britta Ismer, et al.
Pageof 21